Company

OnKure Therapeutics, Inc.

OKUR · CIK 0001637715

SEC FORM 4

$258.76

Sale of 87 shares at $2.9742 per share.

Reporting Person Saccomano Nicholas A · Officer Title President and CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001609284-26-000005 · filed 2026-09-23 · View filing →

SEC FORM 4

$898.21

Sale of 302 shares at $2.9742 per share.

Reporting Person Leverone Jason A. · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001692747-26-000005 · filed 2026-09-23 · View filing →